Global life science partnering for biopharma, medtech, and investors | Back Bay Life Science

The 5th Annual Nordic American Life Science Conference Virtual

Celebrating Nordic American Life Science Investment and Partnering

The Fifth Annual Nordic American Life Science Conference Digital offers a uniquely Nordic-US experience and the opportunity to connect global investors with Nordic life science advancements. This high-visibility forum nurtures robust global life sciences development and provides insight into the Nordic companies breaking new ground in BioPharma and MedTech.

Through a partnership with DNB, Nasdaq, and Business Sweden, and with Back Bay Life Science Advisors, the NALS Conference brings together dozens of private and publicly-listed Nordic healthcare companies, life science organizations, institutional and private investors, innovation scouts, and other industry leaders to learn about advances in oncology, rare disease, neurology, and many other therapeutic areas.

Typically, the conference attracts more than 250 representatives and spans three days, showcasing featuring presentations by promising Nordic life science companies, and expert panel discussions on business development.

The event cumulates in Markets Day 2020, featuring a private company track with late stage/pre-IPO companies.

Registration is complimentary for invited attendees. We look forward to seeing you at the Nordic American Life Science Conference 2020.

Expert insights for corporate and investor communities into the thriving Nordic life science ecosystems.
Connection to institutional investors, prominent public companies, partners, DNB research analysts, bankers, and Back Bay strategists.
Knowledge of global drivers in biotech and MedTech development in Nordic geographies; identification into investment opportunities.

2020 PROGRAM

For 2020, the Nordic American Life Science Conference will be all-virtual and company presentations and expert roundtables. Registration is complimentary: